| human | Q5 |
| P6178 | Dimensions author ID | 01047215667.25 |
| P1006 | Nationale Thesaurus voor Auteursnamen ID | 32691420X |
| P496 | ORCID iD | 0000-0002-0518-8386 |
| P3829 | Publons author ID | 2672393 |
| P1053 | ResearcherID | B-4504-2013 |
| P10861 | Springer Nature person ID | 01047215667.25 |
| P214 | VIAF ID | 289216831 |
| P10832 | WorldCat Entities ID | E39PBJkHpFQgFVBDk8mjTTVV4q |
| P166 | award received | Member of the Order of Australia | Q9678710 |
| Fellow of the Australian Academy of Health and Medical Sciences | Q59771619 | ||
| P69 | educated at | University of Western Australia | Q1517021 |
| P108 | employer | University of Queensland | Q866012 |
| P734 | family name | Thomas | Q1413324 |
| Thomas | Q1413324 | ||
| Thomas | Q1413324 | ||
| P106 | occupation | researcher | Q1650915 |
| rheumatologist | Q5997943 | ||
| P21 | sex or gender | female | Q6581072 |
| Q104744655 | Streptococcus species enriched in the oral cavity of patients with RA are a source of peptidoglycan-polysaccharide polymers that can induce arthritis in mice |
| Q27680522 | A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis |
| Q52668619 | A peripheral blood transcriptomic signature predicts autoantibody development in infants at risk of type 1 diabetes. |
| Q39439305 | A physiological function of inflammation-associated SerpinB2 is regulation of adaptive immunity |
| Q81298773 | Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-kappaB-mediated signalling, moderated by TGF-beta |
| Q39933853 | Antigen-encoding bone marrow terminates islet-directed memory CD8+ T-cell responses to alleviate islet transplant rejection |
| Q77627717 | Antigen-presenting cells in rheumatoid arthritis |
| Q78804319 | Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10 |
| Q80544759 | Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB |
| Q46098672 | Antigen-specific suppression of inflammatory arthritis using liposomes. |
| Q72727584 | Assessment of a positive selection technique using an avidin column to isolate human peripheral blood T cell subsets |
| Q77174764 | Association of clinical, radiological and synovial immunopathological responses to anti-rheumatic treatment in rheumatoid arthritis |
| Q125185605 | Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry |
| Q83648576 | Autoimmunity: innovation in pathogenesis and therapy |
| Q47223029 | B cell chronic lymphocytic leukaemia cells have reduced capacity to upregulate expression of MHC class I in response to interferon-gamma |
| Q71634792 | CD80 expression in rheumatoid arthritis: comment on the article by Ranheim and Kipps |
| Q64929171 | Cardiorespiratory fitness in patients with rheumatoid arthritis is associated with the patient global assessment but not with objective measurements of disease activity. |
| Q33766283 | Cardiovascular disease is increased prior to onset of rheumatoid arthritis but not osteoarthritis: the population-based Nord-Trøndelag health study (HUNT) |
| Q36392394 | Cells of the synovium in rheumatoid arthritis. Dendritic cells. |
| Q57221897 | Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype–positive rheumatoid arthritis patients |
| Q40609782 | Clinical response after intradermal immature dendritic cell vaccination in metastatic melanoma is associated with immune response to particulate antigen. |
| Q48024302 | Co-delivery of antigen and a lipophilic anti-inflammatory drug to cells via a tailorable nanocarrier emulsion. |
| Q52944275 | Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity. |
| Q38489669 | Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens |
| Q73521666 | Comparison of differentiated dendritic cell infiltration of autoimmune and osteoarthritis synovial tissue |
| Q41305375 | Could endogenous self-peptides presented by dendritic cells initiate rheumatoid arthritis? |
| Q87590032 | Current smoking is associated with incident ankylosing spondylitis -- the HUNT population-based Norwegian health study |
| Q38078552 | Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis. |
| Q38175811 | Dendritic cells as targets or therapeutics in rheumatic autoimmune disease. |
| Q90771405 | Dendritic cells, T cells and their interaction in rheumatoid arthritis |
| Q44944872 | Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells |
| Q53182484 | Development and performance evaluation of novel nanoparticles of a grafted copolymer loaded with curcumin. |
| Q73678518 | Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates |
| Q57252638 | Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation |
| Q57252628 | Effector and regulatory T-cell function is differentially regulated by RelB within antigen-presenting cells during GVHD |
| Q72402098 | Elevated interleukin-10 levels in patients with rheumatoid arthritis |
| Q97681821 | Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cells |
| Q57667239 | Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis |
| Q40110847 | Eomesodermin promotes the development of type 1 regulatory T (TR1) cells. |
| Q37374541 | Functional CD40 ligand is expressed by T cells in rheumatoid arthritis |
| Q46752301 | Generation and maturation of dendritic cells for clinical application under serum-free conditions |
| Q37842142 | High Chlamydia Burden Promotes Tumor Necrosis Factor-Dependent Reactive Arthritis in SKG Mice. |
| Q37246396 | High avidity autoreactive T cells with a low signalling capacity through the T-cell receptor: central to rheumatoid arthritis pathogenesis? |
| Q34065740 | IL-1 signalling determines the fate of skin grafts expressing non-self protein in keratinocytes |
| Q91282563 | IL-23 favours outgrowth of spondyloarthritis-associated pathobionts and suppresses host support for homeostatic microbiota |
| Q36577401 | IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis |
| Q56959405 | IL10 and IL12B polymorphisms each influence IL-12p70 secretion by dendritic cells in response to LPS |
| Q38273239 | Identification of self-antigen-specific T cells reflecting loss of tolerance in autoimmune disease underpins preventative immunotherapeutic strategies in rheumatoid arthritis |
| Q37186226 | Immune deficiency or hyperactivity-Nf-kappab illuminates autoimmunity. |
| Q41869061 | Immunogenic, but not steady-state, antigen presentation permits regulatory T-cells to control CD8+ T-cell effector differentiation by IL-2 modulation. |
| Q44638428 | Immunotherapy with costimulatory dendritic cells to control autoimmune inflammation |
| Q37206972 | Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis. |
| Q34448684 | Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy |
| Q57109970 | Interleukin-23 mediates the intestinal response to microbial β-1,3-glucan and the development of spondyloarthritis pathology in SKG mice |
| Q35518655 | Langerhans cells are precommitted to immune tolerance induction |
| Q73828511 | Metastatic lesions in the joint associated with acute inflammatory arthritis after dendritic cell immunotherapy for metastatic melanoma |
| Q40466499 | Monocyte-derived DC primed with TLR agonists secrete IL-12p70 in a CD40-dependent manner under hyperthermic conditions. |
| Q89930593 | Mortality is increased in patients with rheumatoid arthritis or diabetes compared to the general population - the Nord-Trøndelag Health Study |
| Q36709522 | NF-kappa B as a therapeutic target in autoimmune disease. |
| Q40156856 | Nasopharyngeal carcinoma-associated Epstein-Barr virus-encoded oncogene latent membrane protein 1 potentiates regulatory T-cell function. |
| Q77899220 | Nuclear RelB+ cells are found in normal lymphoid organs and in peripheral tissue in the context of inflammation, but not under normal resting conditions |
| Q73319954 | Peripheral blood chimerism following human liver transplantation |
| Q33290218 | Plasmodium strain determines dendritic cell function essential for survival from malaria |
| Q85238171 | Pneumococcal conjugate vaccine-induced regulatory T cells suppress the development of allergic airways disease |
| Q41145666 | Presentation of self peptides by dendritic cells: possible implications for the pathogenesis of rheumatoid arthritis |
| Q28178333 | Recent advances on the role of CD40 and dendritic cells in immunity and tolerance |
| Q35869041 | Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis |
| Q39162620 | Receptor-specific delivery of protein antigen to dendritic cells by a nanoemulsion formed using top-down non-covalent click self-assembly |
| Q53210404 | Reduced interleukin-2 responsiveness impairs the ability of Treg cells to compete for IL-2 in nonobese diabetic mice. |
| Q84512211 | Reduced soluble receptor for advanced glycation end-products in COPD |
| Q72547399 | Reduction of leukocyte and interleukin-1 beta concentrations in the synovial fluid of rheumatoid arthritis patients treated with methotrexate |
| Q89947228 | Regulatory T Cells Induced by Single-Peptide Liposome Immunotherapy Suppress Islet-Specific T Cell Responses to Multiple Antigens and Protect from Autoimmune Diabetes |
| Q46403986 | RelB and the aryl hydrocarbon receptor: dendritic cell tolerance at the epithelial interface |
| Q39682474 | RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells |
| Q35292814 | RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function. |
| Q24803551 | Rheumatoid arthritis synovium contains plasmacytoid dendritic cells |
| Q72296722 | Rheumatoid synovial T cells are functionally active and can contribute to the pathogenesis of rheumatoid arthritis: comment on the article by Matthews et al |
| Q67973883 | Rheumatoid synovium is enriched in CD45RBdim mature memory T cells that are potent helpers for B cell differentiation |
| Q35771423 | Role of genetics in infection-associated arthritis |
| Q41348100 | Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis. |
| Q36347874 | Self-reported Diagnosis of Rheumatoid Arthritis or Ankylosing Spondylitis Has Low Accuracy: Data from the Nord-Trøndelag Health Study. |
| Q37206919 | Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis |
| Q46985397 | Shortcomings of protein removal prior to high performance liquid chromatographic analysis-A case study using method development for BAY 11-7082. |
| Q84185759 | Steady-state dendritic cells continuously inactivate T cells that escape thymic negative selection |
| Q57667259 | Steady-state dendritic cells expressing cognate antigen terminate memory CD8+ T-cell responses |
| Q84357754 | Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells |
| Q73682314 | Surface markers and transendothelial migration of dendritic cells from elderly subjects |
| Q73115107 | Surfactant treatment for osteoarthritis |
| Q37689794 | Synovial fluid CD1c+ myeloid dendritic cells – the inflammatory picture emerges |
| Q36246006 | T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles |
| Q90257384 | T-cell receptor immunosequencing reveals altered repertoire diversity and disease-associated clonal expansions in ankylosing spondylitis patients |
| Q37993692 | T-cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man. |
| Q38089715 | Targeted delivery of curcumin for treating type 2 diabetes. |
| Q44234403 | Targeting antigen to diverse APCs inactivates memory CD8+ T cells without eliciting tissue-destructive effector function |
| Q35405562 | Targeting curcusomes to inflammatory dendritic cells inhibits NF-κB and improves insulin resistance in obese mice |
| Q37689670 | Th17 and Th22 cells in psoriatic arthritis and psoriasis |
| Q24810489 | The TRAF6-NF kappa B signaling pathway in autoimmunity: not just inflammation. |
| Q37724190 | The balancing act of autoimmunity: central and peripheral tolerance versus infection control. |
| Q42282964 | Tolerance induction with gene-modified stem cells and immune-preserving conditioning in primed mice: restricting antigen to differentiated antigen-presenting cells permits efficacy |
| Q37065251 | Trajectory of intensive treat-to-target disease modifying drug regimen in an observational study of an early rheumatoid arthritis cohort |
| Q41563600 | Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features. |
| Q77980157 | Tumor metastasis biopsy as a surrogate marker of response to melanoma immunotherapy |
| Q35210622 | ZAP-70 genotype disrupts the relationship between microbiota and host, leading to spondyloarthritis and ileitis in SKG mice. |
| Q33590483 | c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells |
| Q57116531 | β-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice |
Search more.